← Leaderboards
Jaspreet Singh
Henry Ford Health System
$3,415,536
Attributed
$4,206,544
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,206,544 · 5
By mechanism
R61$1,582,016 · 1
R01$1,404,090 · 1
R21$844,188 · 2
R56$376,250 · 1
Top collaborators
- S. Ali Fatemi2 shared
Others in their field
Other Emerging Leaders on “Female”
- Greg Yothers · University Of Chicago$35,003,821
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,407,352
- Nadine Georges Rouphael · Emory University$13,654,706
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Alberto Rafael Ramos · University Of Miami School Of Medicine$11,170,423
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
Research focus
FemaleMetabolomicsVery Long Chain Fatty AcidPublic HealthGenetic DiseasesClinical PredictorsNeonatal ScreeningMutationNeurologicPlasmaAdrenoleukodystrophyDisease ProgressionAreaGenesAdrenomyeloneuropathyMaleLaboratoriesAutopsyClinical Course Of DiseaseDistantDefectInnovationInvestigationBiochemical
Grant awards (10)
Discovery and validation of multi-omic plasma biomarkers for Adrenomyeloneuropathy$752,390
R61 · FY2025 · NS
Discovery and validation of multi-omic plasma biomarkers for Adrenomyeloneuropathy$829,626
R61 · FY2024 · NS
Use of IPSC to define role of astrocytes in specifying risk for onset of cerebral adrenoleukodystrophy$343,065
R01 · FY2024 · NS · contact PI
Use of IPSC to define role of astrocytes in specifying risk for onset of cerebral adrenoleukodystrophy$353,675
R01 · FY2023 · NS · contact PI
Use of IPSC to define role of astrocytes in specifying risk for onset of cerebral adrenoleukodystrophy$353,675
R01 · FY2022 · NS · contact PI
Use of IPSC to define role of astrocytes in specifying risk for onset of cerebral adrenoleukodystrophy$353,675
R01 · FY2021 · NS · contact PI
Deciphering neuroinflammation-specific regulatory RNA and metabolic networks in human iPSC-derived astrocytes in cerebral adrenoleukodystrophy$413,875
R21 · FY2020 · NS · contact PI
Use of IPSC to define role of astrocytes in specifying risk for onset of cerebral adrenoleukodystrophy$376,250
R56 · FY2020 · NS · contact PI
Plasma biomarkers of cerebral disease in X-linked adrenoleukodystrophy$190,059
R21 · FY2019 · NS · contact PI
Plasma biomarkers of cerebral disease in X-linked adrenoleukodystrophy$240,254
R21 · FY2018 · NS · contact PI